Viatris Inc. buy melinda
Start price
04.10.17
/
50%
€34.35
Target price
29.12.17
€42.39
Performance (%)
10.68%
End price
29.12.17
€38.02
Summary
This prediction ended on 29.12.17 with a price of €38.02. The prediction had a final performance of 10.68%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Viatris Inc. | -6.788% | -6.788% | 76.285% | 41.980% |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% | 62.272% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% | 85.454% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% | 76.580% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% | 68.715% |
Comments by melinda for this prediction
In the thread Viatris Inc. diskutieren
Der Kurs MYL Mylan Inc. zu folgen hat einen neuen Höchststand von 26 Wochen erreicht
$$
Die Mylan Inc MYL Preis hat einen neuen Höchststand von 26 Wochen erreicht
NV Mylan (MYL) gewinnt FDA - Zulassung für die erste Generation Copaxone; Die Aktie stieg um 17%
(Vom Mitglied beendet)